Asparaginase inhibits the lectin pathway of complement activation

Keyphrases

• L-asparaginase 100%
• Complement Activation 100%
• Complement Lectin Pathway 100%
• Acute Lymphoblastic Leukemia 33%
• Clinical Parameters 33%
• Dose Effect 33%
• Ex Vivo Studies 33%
• Innate Immune Response 33%
• Infection Risk 33%
• Inhibitory Effect 33%
• Oncological Treatment 33%
• Oncologic Therapy 33%
• Therapeutic Regimen 33%
• Complement System 33%
• Pancytopenia 33%
• Lectin Pathway 33%
• Observational Clinical Study 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Asparaginase 100%
• Lectin 100%
• Clinical Study 33%
• Acute Lymphoblastic Leukemia 33%
• Infection 33%
• Prevalence 33%
• Pancytopenia 33%

Immunology and Microbiology

• Complement Activation 100%
• Lectin Pathway 100%
• Prevalence 33%
• Innate Immune System 33%
• Complement System 33%